In our case, tumor cells were positive for BOB1, MUM1, and EBER-ISH, partially positive for CD79a, and negative for CD20, CD56, CD138, CD3, CD5, AE1/AE3, and HHV8, which was most consistent with plasmablastic lymphoma. This evidence concerns the gene CD79A and neoplasm.